Successful Treatment of Paecilomyces lilacinus Onychomycosis with Efinaconazole and Tavaborole
暂无分享,去创建一个
[1] S. Lipner,et al. Efinaconazole in the treatment of onychomycosis , 2015, Infection and drug resistance.
[2] B. Elewski,et al. Tavaborole for the treatment of onychomycosis , 2014, Expert opinion on pharmacotherapy.
[3] J. D. Del Rosso. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. , 2014, The Journal of clinical and aesthetic dermatology.
[4] H. Huemer,et al. Persisting Paecilomyces lilacinus nail infection following pregnancy , 2011, Mycoses.
[5] J. Houbraken,et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. , 2011, FEMS microbiology letters.
[6] E. Mellado,et al. Susceptibility Testing and Molecular Classification of Paecilomyces spp , 2008, Antimicrobial Agents and Chemotherapy.
[7] N. Okhravi,et al. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[8] J. Walsh,et al. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature , 2004, International journal of dermatology.
[9] M. Rupp,et al. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. , 2002, Medical mycology.
[10] Hay,et al. Onychomycosis caused by infection with Paecilomyces lilacinus , 1998, The British journal of dermatology.